drop glp 1 GLP-1 RA Adherence Shows Drop-Off After Year Most of the conversation around

Another headline-making study released at the conference , which also looked at medical records involving roughly 110,000 female patients, found those who took GLP-1s were up to 35 per cent less likely to develop breast cancer than those who didn't take the drug

End-Users 17.8

After treatment initiation with liraglutide 3.0 mg, it is recommended that, if a patient has not lost at least 4% of their baseline body weight after 16 weeks, the treatment should be discontinued because it is unlikely that significant weight loss will be achieved with the medication after this time point [21]

All articles Are GLP-1 Medications Safe for Thyroid Disorders